Regular usage of the device, which costs about $100,000, would prevent costly complications that often arise in people who can’t walk, including pressure sores and urinary, digestive, circulatory, and cardiovascular problems.
The ReWalk weighs 15 kg (33 lbs.) and is designed to serve as a physical training device for those undergoing rehabilitation. By maintaining users upright on a daily basis it also helps alleviate many of the health-related problems associated with long-tern wheelchair use such as urinary, respiratory, cardiovascular and digestive problems.
The ReWalk has been undergoing clinical trials in Israel and the U.S. for several years and Argo Medical Technologies now plans to start selling the device to rehabilitation centers around the world from January 2011 for a cost of around US$100,000.
var MarketGidDate = new Date();